Pedersen N L, Nagain-Domaine C, Mahé S, Chariot J, Rozé C, Tomé D
UMR PNCA, Unité de Physiologie de la Nutrition et du Comportement Alimentaire, INA P-G, 16 rue Claude Bernard, F-75231 Cedex 05, Paris, France.
Peptides. 2000 Oct;21(10):1527-35. doi: 10.1016/s0196-9781(00)00307-7.
The effect of caseinomacropeptide (CMP) (the [106-169] fragment of kappa-casein produced during digestion of milk protein), was studied in anesthetized rats using bile diversion for a pure pancreatic juice collection system. Intraduodenal administration of CMP induced a dose-related specific stimulation of pancreatic secretion which was nearly abolished by devazepide, atropine, hexamethonium, vagotomy or perivagal capsaicin pretreatment. Moreover, CMP did not inhibit in vitro trypsin activity. These results demonstrate that CMP is more likely to stimulate pancreatic secretion specifically through cholecystokinin release and activation of a vago-vagal cholinergic reflex loop than by inhibition of luminal trypsin, in anesthetized rats.
利用胆汁分流建立纯胰液收集系统,在麻醉大鼠中研究了酪蛋白巨肽(CMP,牛奶蛋白消化过程中产生的κ-酪蛋白的[106 - 169]片段)的作用。十二指肠内给予CMP可引起与剂量相关的胰腺分泌特异性刺激,而地伐西匹、阿托品、六甲铵、迷走神经切断术或迷走神经周围辣椒素预处理可几乎完全消除这种刺激。此外,CMP在体外并不抑制胰蛋白酶活性。这些结果表明,在麻醉大鼠中,CMP更有可能通过胆囊收缩素释放和迷走-迷走胆碱能反射环的激活来特异性刺激胰腺分泌,而不是通过抑制肠腔胰蛋白酶。